EON Network: December 2025 Newsletter |
The EON Network was established to facilitate communication between exercise oncology and oncology nutrition researchers and clinicians to achieve our joint goal of improving cancer treatment outcomes.
The EON Network monthly newsletter includes upcoming webinars, updates on exercise oncology and oncology nutrition related events, publications that may be of interest, and resources. This information is also available on the EON Network webpage. Past newsletters are archived.
|
|
|
EON Webinar Series: 2025-2026 Presenters
|
The EON Webinar Series has an outstanding group of speakers for this season! Read on for information on upcoming webinars in the series.
|
|
|
February 26, 2026 | 3:00 - 4:00 PM ET
|
|
|
| Improving Oncology Outcomes Through Targeted Nutritional Assessment and Intervention
Cancer and its treatments substantially impact nutritional status and overall patient outcomes. Malnutrition and muscle loss are highly prevalent challenges that compromise treatment tolerance, increase toxicity, and diminish quality of life and survival. This presentation will highlight emerging evidence on the role of targeted nutrition strategies, emphasizing the importance of comprehensive assessment and individualized intervention. Drawing on data from clinical trials and translational research, the session will explore updated insights into energy and protein requirements in oncology, including how factors such as inflammation influence anabolic response. It will also underscore the importance of integrating nutrition into multidisciplinary cancer care to optimize outcomes across the continuum.
|
|
|
April 9, 2026 | 2:00 - 3:00 PM ET
|
|
|
| Coffee consumption and improved colorectal cancer survivorship: from observational to interventional studies
Observational findings from several independent cohorts have consistently shown a beneficial association of coffee consumption after diagnosis with better survival outcomes among patients with colorectal cancer. In support of these data, coffee has been linked to lower risk of metabolic disorders, lower inflammation, and favorable blood biochemical profiles. While the components in coffee that drive these benefits remain unknown, studies of metabolomics and microbiome have identified potential molecules and mechanisms of action underlying coffee's beneficial effects. These data altogether have motivated the conduct of the first randomized control trial of coffee consumption among colorectal cancer survivors (the COMMENCER trial). In this presentation, Dr. Song will review the existing data, present the COMMENCER trial, and discuss the future directions.
|
|
|
In Case You Missed It: Past Webinars
|
|
|
Oncology-focused Postdoctoral Training In Care Delivery and Symptom Science (OPTICS) Training Program (NCI T32) at Memorial Sloan Kettering
|
Funded by a National Cancer Institute research training grant (1T32CA275764-01A1), the Oncology-focused Postdoctoral Training In Care Delivery and Symptom Science (OPTICS) Training Program at Memorial Sloan Kettering Cancer Center (MSK) will mentor and train physicians and scientists with PhD/ScDs in social or quantitative sciences to conduct research focused on innovative cancer care delivery.
The cornerstone of the OPTICS program will be a two-year mentored research experience in which trainees will conduct research aligned with one or more of four thematic areas: Data Science, Risk Mitigation, Symptom Science, & Care Delivery
The OPTICS program, led by Katherine Panageas, Deb Schrag, Jun J. Mao, and Jonine Bernstein, of the Department of Medicine and the Department of Epidemiology and Biostatistics, aims to train physicians and researchers in quantitative or social sciences in innovative cancer care delivery research that bridges the gap between the outcomes that could be achieved based on existing knowledge and the outcomes that are actually achieved in cancer care. To gain foundational knowledge in the themes mentioned above, trainees will acquire expertise in essential research methods, complete an original research study aligned with one or more of these themes, with close mentorship from program faculty, and develop the core professional skills necessary to launch an impactful career in cancer-focused population science.
For more information visit here.
|
Transdisciplinary Research on Energetics and Cancer (TREC) Training Workshop 2026
|
The Transdisciplinary Research on Energetics and Cancer (TREC) Training Workshop builds upon the NCI TREC Initiative and covers topics across the cancer control and T0-T4 continua.
Now in our 10th year, this Workshop is funded by the National Cancer Institute and led by Yale University’s Dr. Melinda Irwin with expert international faculty. TREC builds collaborations among basic sciences, clinician-researchers, and population scientists in energy balance and cancer research. The program is designed for junior faculty and postdocs. This 5-day, in residence Workshop places emphasis on developing and applying transdisciplinary and translational competencies focused on energetics (obesity, diet and exercise) and cancer. Expert faculty and fellow alumni span an array of professional disciplines, from basic scientists to clinicians to behavioral and population scientists. Formal didactic learning is integrated with one-on-one dialog and small group discussions to enable fellows to learn from each other and from faculty, and to develop a TREC network.
The 10th annual course will be held June 22-26, 2026 at Water’s Edge Resort, Westbrook, CT. Costs are covered.
Notification of Intent to apply (simple, informal email to dlowry@fredhutch.org) due no later than December 20, 2025.
Full application is due no later than January 20, 2026.
For more detail and to apply, visit TRECTraining.yale.edu.
Questions: contact Diana Lowry dlowry@fredhutch.org.
|
Invitation to Submit Additional Opportunities
|
Opportunities such as training workshops, publication submissions, and funding applications are great to share with the EON Network. We invite all to submit relevant opportunities by emailing eonnetwork@bsc.gwu.edu!
|
|
|
Schmitz KH, Ligibel JA. If exercise were a pill, we'd all prescribe it to patients with cancer. But it's not. J Clin Oncol 2025 Nov 21:JCO2501649. Epub ahead of print. PMID: 41270257
Grønset CN, Jarden M, Christensen J, Simonsen C, Tolver A, Suetta C, Hutchings M. Changes in lean muscle mass, muscle strength, and physical performance following first-line chemotherapy in patients with lymphoma. Hematol Oncol 2025;43(6):e70154. PMID: 41186167
Mendez V, Diedrichsen Marstrand S, Nielsen A, Lund-Jacobsen T, Kistorp C, Schwarz P, Buch-Larsen K. Body composition changes in women with early breast cancer after adjuvant treatment: a systematic review. Acta Oncol 2025;64:1640-1647. PMID: 41355184
Butler TO, Elliott JA, Davey MG, Collins PM, McNamara M, O'Malley E, Brennan MJ, Barry K, Abd Elwahab S, Sweeney K, Malone C, McLaughlin R, Lowery A, Kerin MJ. Effect of sarcopenia on treatment response and operative and oncological outcomes among patients undergoing neoadjuvant chemotherapy for breast cancer. BJS Open 2025;9(6):zraf128. PMID: 41189487
Hall LH, Green SMC, Haider Z, Fisher A, King N, Beeken RJ, Smith SG. Physical activity interventions for women with metastatic breast cancer: a systematic review of published and ongoing randomised controlled trials. J Cancer Surviv 2025 Nov 11. Epub ahead of print. PMID: 41214274
Harper K, Adintori PA, Heimgartner J, Schmidt E, Carpenter PA, Ullrich C. Best practice considerations in nutritional care for adult patients undergoing hematopoietic cell transplantation. Transplant Cell Ther 2025 Nov 22:S2666-6367(25)01596-9. Epub ahead of print. PMID: 41285296
Shah UA, Cogrossi LL, Garces JJ, Policastro A, Castro F, Derkach A, Fei T, DeWolf S, Grioni M, Sisti S, Blaslov J, Adintori PA, Hosszu KK, McAvoy D, Baichoo M, Cross JR, Paredes J, Anuraj A, Raj SS, Pohl C, Zordan P, Zinsmeyer V, Jesus Faustino Ramos RJ, Lorenzoni M, Gipson B, Maclachlan KH, Gradissimo A, Boiocchi L, Aleynick N, Marchigiani C, Pagani S, Salehi E, Koche RP, Chaligne R, Block T, Korde N, Tan CR, Hultcrantz M, Hassoun H, Shah GL, Scordo M, Lahoud OB, Chung DJ, Landau HJ, Peled JU, Clementi N, Chesi M, Bergsagel PL, Mailankody S, Pollak MN, D'Souza A, Landgren O, Chimonas S, Giralt SA, Usmani SZ, Iyengar NM, Lesokhin AM, van den Brink MRM, Bellone M. A high-fiber plant-based diet in myeloma precursor disorders - Results from the NUTRIVENTION clinical trial and preclinical Vk*MYC model. Cancer Discov 2025 Dec 4. Epub ahead of print. PMID: 41342739
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
6110 Executive Blvd Suite 750 | Rockville, MD 20852 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
| |
|
|
